Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The adhesion modulating properties of tenascin-W.
Brellier F, Martina E, Chiquet M, Ferralli J, van der Heyden M, Orend G, Schittny JC, Chiquet-Ehrismann R, Tucker RP. Brellier F, et al. Among authors: martina e. Int J Biol Sci. 2012;8(2):187-94. doi: 10.7150/ijbs.8.187. Epub 2011 Dec 20. Int J Biol Sci. 2012. PMID: 22211116 Free PMC article.
Tenascin-W is a specific marker of glioma-associated blood vessels and stimulates angiogenesis in vitro.
Martina E, Degen M, Rüegg C, Merlo A, Lino MM, Chiquet-Ehrismann R, Brellier F. Martina E, et al. FASEB J. 2010 Mar;24(3):778-87. doi: 10.1096/fj.09-140491. Epub 2009 Nov 2. FASEB J. 2010. PMID: 19884327 Free PMC article.
In conclusion, our study identifies tenascin-W as a candidate biomarker for brain tumor angiogenesis that could be used as a molecular target for therapy irrespective of the glioma subtype.-Martina, E., Degen, M., Ruegg, C., Merlo, A., Lino, M. M., Chiquet-Ehrismann …
In conclusion, our study identifies tenascin-W as a candidate biomarker for brain tumor angiogenesis that could be used as a molecular targe …
SMOC1 is a tenascin-C interacting protein over-expressed in brain tumors.
Brellier F, Ruggiero S, Zwolanek D, Martina E, Hess D, Brown-Luedi M, Hartmann U, Koch M, Merlo A, Lino M, Chiquet-Ehrismann R. Brellier F, et al. Among authors: martina e. Matrix Biol. 2011 Apr;30(3):225-33. doi: 10.1016/j.matbio.2011.02.001. Epub 2011 Feb 21. Matrix Biol. 2011. PMID: 21349332
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens.
Stingeni L, Bianchi L, Caroppo ES, Belloni Fortina A, Caroppo F, Corazza M, Borghi A, Gallo R, Trave I, Ferrucci SM, Beretta A, Guarneri F, Martina E, Napolitano M, DE Lucia M, Patruno C, Bennardo L, Romita P, Foti C, Tramontana M, Marietti R, Argenziano G, Hansel K; Skin Allergy group of SIDeMaST and Società Italiana di Dermatologia Allergologica, Professionale e Ambientale (SIDAPA). Stingeni L, et al. Among authors: martina e. Ital J Dermatol Venerol. 2024 Apr;159(2):83-104. doi: 10.23736/S2784-8671.24.07733-8. Ital J Dermatol Venerol. 2024. PMID: 38650492 Free article.
Contact allergy to SIDAPA baseline series allergens in patients with eyelid dermatitis: An Italian multicentre study.
Stingeni L, Foti C, Guarneri F, Corazza M, Cristaudo A, Ferrucci SM, Gallo R, Martina E, Musumeci ML, Napolitano M, Nettis E, Patruno C, Pigatto PD, Piras V, Schena D, Casciola G, Antonelli E, Hansel K; SIDAPA Study Group. Stingeni L, et al. Among authors: martina e. Contact Dermatitis. 2024 May;90(5):479-485. doi: 10.1111/cod.14507. Epub 2024 Jan 24. Contact Dermatitis. 2024. PMID: 38268123
85 results